Skip to main content
Kenneth Shroyer, MD, Pathology, Stony Brook, NY, Stony Brook University Hospital

KennethReedShroyerMDPhD

Pathology Stony Brook, NY

Cytopathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Professor and Chair Department of Pathology School of Medicine Stony Brook University

Dr. Shroyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shroyer's full profile

Already have an account?

Summary

  • Dr. Kenneth Shroyer is a pathologist in Stony Brook, NY and is affiliated with Stony Brook University Hospital. He received his medical degree from University of Colorado School of Medicine and has been in practice 30 years. He specializes in cytopathology, anatomic pathology, clinical pathology, and surgical pathology and is experienced in cytopathology, surgical pathology, biomedical research, and pathology.

Education & Training

  • University of Colorado
    University of ColoradoResidency, Pathology-Anatomic and Clinical, 1987 - 1991
  • University of Colorado School of Medicine Anschutz Medical Campus
    University of Colorado School of Medicine Anschutz Medical CampusClass of 1987

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2024
  • CO State Medical License
    CO State Medical License 1988 - 2009
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Cytopathology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Keratin 17 Is a Sensitive and Specific Biomarker of Urothelial Neoplasia  
    Daniel C Mockler, Shahram S Gholami, Kenneth R Shroyer, Richard Moffitt, Nam W Kim, Nature

Press Mentions

  • Urine Test Detects New or Returning Bladder Cancer
    Urine Test Detects New or Returning Bladder CancerJune 9th, 2021
  • New Non-Invasive Test Can Detect Bladder Cancer
    New Non-Invasive Test Can Detect Bladder CancerJune 4th, 2021
  • Meet Our 2018 Research Grantees: Translational Awards
    Meet Our 2018 Research Grantees: Translational AwardsJuly 18th, 2018
  • Join now to see all

Grant Support

  • P16 And HPV In Low-Grade Cervical Cytologic SpecimensNational Cancer Institute2007
  • P16 And HPV In Low-Grade Cervical Cytologic SpecimensNational Cancer Institute2005–2007
  • P16 And HPV In Low-Grade Cervical Cytologic SpecimensNational Cancer Institute2004
  • Telomerase And HPV In PAP Smears And Cervical BiopsiesNational Cancer Institute1999–2001
  • Clonality In Endometrium And OvaryNational Cancer Institute1993

Research History

  • Principal InvestigatorResearch in my lab has included the discovery and validation of diagnostic, prognostic, and predictive cancer biomarkers, including X-chromosome inactivation, telomerase, p16INK4a, and B7-H4, impacting concepts on the interaction of tumor cells with the inflammatory microenvironment.1991 - Present

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Scientific Advisory Board Member, KDx Inc.2015 - Present